Advertisements



vTv Therapeutics Fails Late-Stage Alzheimer"s Study; Is There A Chance For A Comeback?

vTv Therapeutics Fails Late-Stage Alzheimer"s Study; Is There A Chance For A Comeback?.....»»

Category: topSource: seekingalphaApr 16th, 2018

Stifel Sees Challenging Road Ahead For vTv Therapeutics After Failed Alzheimer"s Trial

vTv Therapeutics Inc (NASDAQ: VTVT) announced Monday after the close that results from Part A of its late-stage study of an investigational medication to treat Alzheimer's disease did not m Latest Ratings for VTVT D.....»»

Category: blogSource: benzingaApr 10th, 2018

Pfizer and Eli Lilly Win in Late-Stage Osteoarthitis Study

Pfizer and Eli Lilly shares were largely unaffected after the firms announced positive results from a joint late-stage trial in patients with osteoarthritis pain......»»

Category: blogSource: 247wallst2 hr. 16 min. ago

Celgene and Acceleron Pharma Win Again in Late-Stage Trial

Acceleron Pharma and Celgene each saw a handy gain on Tuesday morning after it was announced results from their late-stage study in adults with transfusion-dependent beta-thalassemia......»»

Category: blogSource: 247wallstJul 10th, 2018

Aquinox Tumbles 82% On Failed Late-Stage Study, But Proof-Of-Concept Trial Might Right The Ship

Aquinox Tumbles 82% On Failed Late-Stage Study, But Proof-Of-Concept Trial Might Right The Ship.....»»

Category: topSource: seekingalphaJul 3rd, 2018

Global Blood Therapeutics shares drop after late-stage data for sickle cell disease treatment

Global Blood Therapeutics Inc. shares dropped as much as 12% in premarket trade on Wednesday after the company reported results for a late-stage trial of sickle cell disease therapy, and said that it met with the U.S. Food and Drug Ad.....»»

Category: topSource: marketwatchJun 27th, 2018

Positive Late-Stage Trial Not Enough to Move the Needle for Pfizer

Pfizer shares slipped slightly on Monday morning after the firm announced results from its late-stage trial of breast cancer. Ultimately the results were positive but not exactly what the study was........»»

Category: blogSource: 247wallstJun 25th, 2018

Sarepta Hits Record High As Duchenne Muscular Dystrophy Gene Therapy Yields Positive Results In Early-Stage Study

Sarepta Therapeutics Inc (NASDAQ: SRPT) shares, halted shortly before Tuesday's open, opened higher by more than 50 percent. read more.....»»

Category: blogSource: benzingaJun 19th, 2018

Teva Fails Late-Stage Trial In Migraine Trial

Teva Fails Late-Stage Trial In Migraine Trial.....»»

Category: topSource: seekingalphaJun 18th, 2018

Eli Lilly, AstraZeneca Drop Two Late-Stage Alzheimer"s Drug Trials

Pharma giants AstraZeneca and Eli Lilly have scrapped two late-stage trials of an experimental Alzheimer’s drug they were co-developing, the latest blow in the long quest to find a breakthrough for the memory-robbing disorder......»»

Category: smallbizSource: wsjJun 12th, 2018

Why Nektar Therapeutics Shares Are Tumbling

Nektar Therapeutics (NASDAQ: NKTR) saw its shares get nearly halved in Monday’s session after the company released preliminary data from its early stage cancer study. The preliminary results........»»

Category: blogSource: 247wallstJun 4th, 2018

AstraZeneca"s Late-Stage Study Win Reinforces Its Hold On Particular Segment Of Lung Cancer Market

AstraZeneca"s Late-Stage Study Win Reinforces Its Hold On Particular Segment Of Lung Cancer Market.....»»

Category: topSource: seekingalphaMay 29th, 2018

Esperion Therapeutics Shares Briefly Halted on Late-Stage Cholesterol Trial

Esperion Therapeutics shares were halted in premarket trading on Wednesday after the firm announced late-stage trial results for its cholesterol drug......»»

Category: blogSource: 247wallstMay 23rd, 2018

Should Nabriva Be Seeing a Better Response for This Positive Trial?

Nabriva Therapeutics watched its shares take a step back on Monday's despite seeing positive results in its late-stage pneumonia trial......»»

Category: blogSource: 247wallstMay 21st, 2018

Nabriva Therapeutics unveils positive results in bacterial pneumonia drug trial

Nabriva Therapeutics PLC on Monday reported positive results in a a late-stage trial of a treatment for bacterial pneumonia, saying the phase 3 trial of Lefamulin Evaluation Against Pneumonia (LE.....»»

Category: topSource: marketwatchMay 21st, 2018

Nabriva Therapeutics announces positive results in late-stage trial of bacterial pneumonia drug

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchMay 21st, 2018

Esperion shares plummet 20% on late-stage trial results

Esperion Therapeutics Inc. sha.....»»

Category: topSource: marketwatchMay 2nd, 2018

Esperion shares halted on positive late-stage trial results

Esperion Therapeutics Inc. shares were halted in premarket trade Wednesday on news of positive results for a late-stage clinical trial of its cholesterol-lowering medication. The phase 3 trial, which enrolled .....»»

Category: topSource: marketwatchMay 2nd, 2018

Biogen will pay $50 million to reduce royalties on Alzheimer"s disease drug

Biogen Inc. said early Tuesday that it will pay $50 million to privately-held Neurimmune to reduce royalty rates on the late-stage Alzheimer's disease drug aducanumab. The 5% reduction will leave royalty rates on potenti.....»»

Category: topSource: marketwatchMay 1st, 2018

Celldex"s Phase II Breast Cancer Study Fails, Shares Plunge

Celldex Therapeutics' (CLDX) glembatumumab vedotin fails to meet primary endpoint in phase IIb METRIC study in metastat.....»»

Category: smallbizSource: nytApr 17th, 2018

Shares of vTv Therapeutics plummet as Alzheimer"s study disappoints

Shares of vTv Therapeutics Inc. plunged in the exte.....»»

Category: topSource: marketwatchApr 9th, 2018